President’s Conversation

Wednesday, October 21, 2020

Navigating cancer and advancing cancer research during the pandemic

Please join Dr. Thomas J. Lynch Jr., Fred Hutch president and director and holder of the Raisbeck Endowed Chair, on Wednesday, October 21, from noon to 1 p.m. PDT for a President's Conversation about the challenge of navigating cancer and advancing cancer research during the pandemic. 

Please RSVP by October 20. After you register, you will receive instructions for how to join the conversation by computer, tablet, or phone. 

Date:
Wednesday, October 21, 2020
Location:
Virtual
Speaker or Presenter:
Dr. Lynch will lead a discussion with a panel of researchers.

Topics and Details

  • Open science is flourishing as researchers share their findings online in real time. 
  • Public interest in scientific research, and how it impacts our daily lives, is skyrocketing.
  • Social distancing is changing the way scientists work — in the lab, the clinic, and the community.

Dr. Lynch will lead a discussion with Drs. Jesse Bloom, Neel Dey, and Ruth Etzioni about these and other new realities scientists are navigating. We'll leave plenty of time to answer your questions.

Dr. Jesse Bloom is an evolutionary biologist and mathematician whose innovative tools are enabling scientists everywhere to understand the immune system’s response to the coronavirus and project how the virus could adapt to escape detection. This work is informing development of drugs and vaccines to fight COVID-19.

Dr. Neel Dey is a physician-researcher who studies how a person’s gut microbiome affects their risk for colorectal cancer. He has extended his research to explore whether strategies that target the microbiome can help patients recover from COVID-19 more quickly.

Dr. Ruth Etzioni, who holds the Rosalie and Harold Rea Brown Endowed Chair, is a biostatistician who primarily focuses on cancer screening and early detection. She has played a prominent role in the national conversation about the value and limitations of models for COVID-19 and other diseases.


We look forward to an engaging conversation!

Topics and Details

  • The effect of COVID-19 on cancer patients 
  • How patient care has adapted, including changes to patient follow-up 
  • The impact on research, clinical trials, and our mission to develop new treatments

Dr. Thomas J. Lynch Jr., Fred Hutch president and director and holder of the Raisbeck Endowed Chair, will lead the discussion with the following Hutch experts: 

Dr. Nancy Davidson, who holds the Raisbeck Endowed Chair for Collaborative Research, is a leader in the field of breast cancer biology and treatment and has made notable advances in breast cancer research and care. She now drives interdisciplinary research through joint leadership of Fred Hutch's Clinical Research Division, Seattle Cancer Care Alliance, and the University of Washington's Division of Medical Oncology. 

Dr. John K. Lee studies epithelial cancers like prostate and bladder, which begin in the cells that line our organs and have been difficult to treat with immunotherapy. Using a pioneering big-data approach, he is uncovering surface proteins on these cancers so they can now be targeted with immunotherapy.

Kristi Stiffler, MPH, is associate vice president for Clinical Research Support. In her role, she is helping to grow the Hutch's clinical research portfolio and ensure we meet the requirements of the National Cancer Institute and regulatory agencies.

We look forward to an engaging conversation!

Last Modified, October 16, 2020